USA flag logo/image

An Official Website of the United States Government

Expression of Dengue Viral Proteins in Drosophila Cells

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
24766
Program Year/Program:
1996 / SBIR
Agency Tracking Number:
24766
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
HAWAII BIOTECH, INC.
99-193 AIEA HEIGHTS DRIVE, SUITE 200 AIEA, HI -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 1996
Title: Expression of Dengue Viral Proteins in Drosophila Cells
Agency: HHS
Contract: 1 R43 AI35401-1,
Award Amount: $742,445.00
 

Abstract:

Dengue virus causes dengue fever, a debilitating illness marked by high fever, headache, muscleand joint pain, and rash. The more severe forms of the illness, dengue hemorrhagic fever and dengueshock syndrome, are life threatening and are a principal cause of hospitalization among children inSoutheast Asia. Globally, the four serotypes of dengue are responsible for up to 100 million infectionsannually, and with the introduction of the WP albopictus vector mosquito to North America, dengue nowposes a threat to the mainland United States. We will develop a safe and effective subunit vaccineagainst dengue infection. The Phase I research will test the feasibility of expressing dengue structuralproteins in a Drosophila cell culture system and examine their association in a lipoprotein particle.Co-expression of the two membrane- anchored structural proteins of a related flavivirus have beenshown to yield highly immunogenic proteins with native conformations in a particle; the Drosophila cellexpression system has expressed high levels (30 mg/L) of recombinant HIV gpl2O with biologicalproperties indistinguishable from viral gpl20. High level Drosophila cell expression of dengue proteinsin a lipoprotein particle form could lead to development of a successful tetravalent dengue subunitvaccine.

Principal Investigator:

John Ivy
8084865333

Business Contact:

Small Business Information at Submission:

Hawaii Biotechnology Group,
99-193 Aiea Heights Drive Aiea, HI 96701

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No